

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of fibrinolysis (GO:0051918) | 8.61816194 |
| 2 | regulation of fibrinolysis (GO:0051917) | 8.14251860 |
| 3 | protein carboxylation (GO:0018214) | 7.90213366 |
| 4 | peptidyl-glutamic acid carboxylation (GO:0017187) | 7.90213366 |
| 5 | regulation of protein activation cascade (GO:2000257) | 7.57386234 |
| 6 | regulation of complement activation (GO:0030449) | 7.32457949 |
| 7 | intestinal cholesterol absorption (GO:0030299) | 6.70183102 |
| 8 | very-low-density lipoprotein particle assembly (GO:0034379) | 6.64867455 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.59087230 |
| 10 | L-phenylalanine catabolic process (GO:0006559) | 6.59087230 |
| 11 | complement activation, alternative pathway (GO:0006957) | 6.57801684 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.44957050 |
| 13 | plasma lipoprotein particle assembly (GO:0034377) | 6.40551606 |
| 14 | regulation of plasminogen activation (GO:0010755) | 6.26266574 |
| 15 | plasma lipoprotein particle remodeling (GO:0034369) | 6.23739226 |
| 16 | protein-lipid complex remodeling (GO:0034368) | 6.23739226 |
| 17 | macromolecular complex remodeling (GO:0034367) | 6.23739226 |
| 18 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.18043975 |
| 19 | L-phenylalanine metabolic process (GO:0006558) | 6.18043975 |
| 20 | cholesterol efflux (GO:0033344) | 6.16971253 |
| 21 | blood coagulation, intrinsic pathway (GO:0007597) | 5.98675616 |
| 22 | regulation of cholesterol esterification (GO:0010872) | 5.92827725 |
| 23 | negative regulation of sterol transport (GO:0032372) | 5.89352145 |
| 24 | negative regulation of cholesterol transport (GO:0032375) | 5.89352145 |
| 25 | high-density lipoprotein particle remodeling (GO:0034375) | 5.82855681 |
| 26 | protein-lipid complex assembly (GO:0065005) | 5.68445418 |
| 27 | regulation of apoptotic cell clearance (GO:2000425) | 5.68063099 |
| 28 | low-density lipoprotein particle remodeling (GO:0034374) | 5.54270351 |
| 29 | plasma lipoprotein particle organization (GO:0071827) | 5.51529962 |
| 30 | reverse cholesterol transport (GO:0043691) | 5.46928733 |
| 31 | fibrinolysis (GO:0042730) | 5.22230198 |
| 32 | protein-lipid complex subunit organization (GO:0071825) | 5.17594566 |
| 33 | plasma lipoprotein particle clearance (GO:0034381) | 5.03970482 |
| 34 | phospholipid efflux (GO:0033700) | 5.00552636 |
| 35 | epoxygenase P450 pathway (GO:0019373) | 4.93953107 |
| 36 | negative regulation of protein activation cascade (GO:2000258) | 4.83380221 |
| 37 | acute-phase response (GO:0006953) | 4.79138769 |
| 38 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.71477785 |
| 39 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.71477785 |
| 40 | glutamate metabolic process (GO:0006536) | 4.62086506 |
| 41 | protein activation cascade (GO:0072376) | 4.59063701 |
| 42 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 4.46529541 |
| 43 | triglyceride homeostasis (GO:0070328) | 4.44941930 |
| 44 | acylglycerol homeostasis (GO:0055090) | 4.44941930 |
| 45 | proline metabolic process (GO:0006560) | 4.40493962 |
| 46 | exogenous drug catabolic process (GO:0042738) | 4.39920995 |
| 47 | negative regulation of hemostasis (GO:1900047) | 4.39122611 |
| 48 | negative regulation of blood coagulation (GO:0030195) | 4.39122611 |
| 49 | regulation of humoral immune response (GO:0002920) | 4.38983720 |
| 50 | intestinal absorption (GO:0050892) | 4.38920035 |
| 51 | ethanol oxidation (GO:0006069) | 4.36342017 |
| 52 | aromatic amino acid family catabolic process (GO:0009074) | 4.31747511 |
| 53 | imidazole-containing compound metabolic process (GO:0052803) | 4.29135055 |
| 54 | glyoxylate metabolic process (GO:0046487) | 4.28764401 |
| 55 | positive regulation of hemostasis (GO:1900048) | 4.26989690 |
| 56 | positive regulation of blood coagulation (GO:0030194) | 4.26989690 |
| 57 | complement activation, classical pathway (GO:0006958) | 4.24988026 |
| 58 | regulation of cholesterol homeostasis (GO:2000188) | 4.21421390 |
| 59 | drug catabolic process (GO:0042737) | 4.18363040 |
| 60 | lipoprotein metabolic process (GO:0042157) | 4.14149631 |
| 61 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.13473432 |
| 62 | omega-hydroxylase P450 pathway (GO:0097267) | 4.11706256 |
| 63 | negative regulation of lipase activity (GO:0060192) | 4.05265405 |
| 64 | urea metabolic process (GO:0019627) | 4.03483210 |
| 65 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.02252251 |
| 66 | negative regulation of coagulation (GO:0050819) | 4.01752623 |
| 67 | cholesterol homeostasis (GO:0042632) | 4.01608432 |
| 68 | regulation of bile acid biosynthetic process (GO:0070857) | 3.99935596 |
| 69 | sterol homeostasis (GO:0055092) | 3.95950240 |
| 70 | sterol transport (GO:0015918) | 3.93780041 |
| 71 | cholesterol transport (GO:0030301) | 3.93780041 |
| 72 | regulation of triglyceride catabolic process (GO:0010896) | 3.92458681 |
| 73 | positive regulation of coagulation (GO:0050820) | 3.89729353 |
| 74 | complement activation (GO:0006956) | 3.89690260 |
| 75 | negative regulation of complement activation (GO:0045916) | 3.86449354 |
| 76 | negative regulation of wound healing (GO:0061045) | 3.85705323 |
| 77 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.83370249 |
| 78 | serine family amino acid catabolic process (GO:0009071) | 3.72914760 |
| 79 | urea cycle (GO:0000050) | 3.67669983 |
| 80 | nitrogen cycle metabolic process (GO:0071941) | 3.60083981 |
| 81 | ethanol metabolic process (GO:0006067) | 3.56628484 |
| 82 | diacylglycerol metabolic process (GO:0046339) | 3.53967095 |
| 83 | cytolysis (GO:0019835) | 3.52526923 |
| 84 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.52014464 |
| 85 | tyrosine metabolic process (GO:0006570) | 3.49954565 |
| 86 | positive regulation of steroid metabolic process (GO:0045940) | 3.48626326 |
| 87 | positive regulation of extracellular matrix organization (GO:1903055) | 3.46959908 |
| 88 | acute inflammatory response (GO:0002526) | 3.44642408 |
| 89 | peptidyl-glutamic acid modification (GO:0018200) | 3.41142358 |
| 90 | lipid homeostasis (GO:0055088) | 3.39182966 |
| 91 | bile acid metabolic process (GO:0008206) | 3.39157501 |
| 92 | negative regulation of digestive system process (GO:0060457) | 3.30069078 |
| 93 | regulation of fatty acid biosynthetic process (GO:0042304) | 3.29164851 |
| 94 | regulation of cholesterol metabolic process (GO:0090181) | 3.26439947 |
| 95 | glycine metabolic process (GO:0006544) | 3.22102795 |
| 96 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.20714828 |
| 97 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.20714828 |
| 98 | negative regulation of lipid transport (GO:0032369) | 3.19318704 |
| 99 | drug metabolic process (GO:0017144) | 3.18562535 |
| 100 | positive regulation of lipid catabolic process (GO:0050996) | 3.15127795 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.16999495 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.29237353 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.84930013 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.31301768 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.30891833 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.22085238 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.17247150 |
| 8 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 3.62952957 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.57076026 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.35366961 |
| 11 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.19964153 |
| 12 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.87845486 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.64709668 |
| 14 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.36489282 |
| 15 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.34570409 |
| 16 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.27413855 |
| 17 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.00652755 |
| 18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.5906123 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.85894955 |
| 20 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.80223372 |
| 21 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.74520328 |
| 22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.59970608 |
| 23 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.59757533 |
| 24 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.56492209 |
| 25 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.52237833 |
| 26 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.45750616 |
| 27 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.42727087 |
| 28 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.38769982 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.36274920 |
| 30 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.35252554 |
| 31 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.32753615 |
| 32 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.26154441 |
| 33 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.21086989 |
| 34 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.19737179 |
| 35 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.18638058 |
| 36 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.15256212 |
| 37 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.12332295 |
| 38 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.09973782 |
| 39 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08439717 |
| 40 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.07835956 |
| 41 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.06762280 |
| 42 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.06533623 |
| 43 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.05386054 |
| 44 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.05036880 |
| 45 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.04242449 |
| 46 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.03726323 |
| 47 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03539264 |
| 48 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.00952299 |
| 49 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.00008439 |
| 50 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.98961854 |
| 51 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.97886260 |
| 52 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.97285406 |
| 53 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.95886465 |
| 54 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.94040300 |
| 55 | P68_20966046_ChIP-Seq_HELA_Human | 0.93777217 |
| 56 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.93015157 |
| 57 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.87692290 |
| 58 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.86309143 |
| 59 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.86232083 |
| 60 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.81530753 |
| 61 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.80151091 |
| 62 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.80065980 |
| 63 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.78493546 |
| 64 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.77320401 |
| 65 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.77230489 |
| 66 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.77009503 |
| 67 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.75530313 |
| 68 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.74968143 |
| 69 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74611235 |
| 70 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.73635926 |
| 71 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.73594448 |
| 72 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.73370100 |
| 73 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.73285376 |
| 74 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.73119628 |
| 75 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.72889721 |
| 76 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.72883271 |
| 77 | * RAC3_21632823_ChIP-Seq_H3396_Human | 0.71686366 |
| 78 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.70178920 |
| 79 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.69422768 |
| 80 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.68871059 |
| 81 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.68856956 |
| 82 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.68580181 |
| 83 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.67563474 |
| 84 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.67062469 |
| 85 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.67029036 |
| 86 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.66672622 |
| 87 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.66452344 |
| 88 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.64748984 |
| 89 | KDM2B_26808549_Chip-Seq_K562_Human | 0.63703585 |
| 90 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.63155148 |
| 91 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.63136936 |
| 92 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.62116714 |
| 93 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.61813517 |
| 94 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.61397986 |
| 95 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.60763950 |
| 96 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.60593855 |
| 97 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.60252324 |
| 98 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.59984352 |
| 99 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.59743491 |
| 100 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.59268975 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.64214059 |
| 2 | MP0005360_urolithiasis | 7.45478267 |
| 3 | MP0005365_abnormal_bile_salt | 5.39664023 |
| 4 | MP0003195_calcinosis | 5.38622786 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.71048990 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 4.70854819 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.90971243 |
| 8 | MP0001666_abnormal_nutrient_absorption | 3.72947762 |
| 9 | MP0003122_maternal_imprinting | 3.24537923 |
| 10 | MP0003252_abnormal_bile_duct | 3.24385383 |
| 11 | MP0000566_synostosis | 2.67090493 |
| 12 | MP0009840_abnormal_foam_cell | 2.41936121 |
| 13 | MP0003868_abnormal_feces_composition | 2.10532942 |
| 14 | MP0005332_abnormal_amino_acid | 2.03893813 |
| 15 | MP0003172_abnormal_lysosome_physiology | 1.98191990 |
| 16 | MP0000609_abnormal_liver_physiology | 1.95083196 |
| 17 | MP0002089_abnormal_postnatal_growth/wei | 1.89442967 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 1.87887992 |
| 19 | MP0003191_abnormal_cellular_cholesterol | 1.86173726 |
| 20 | MP0005451_abnormal_body_composition | 1.82151693 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 1.81693624 |
| 22 | MP0010368_abnormal_lymphatic_system | 1.73371240 |
| 23 | MP0005408_hypopigmentation | 1.68609545 |
| 24 | MP0005058_abnormal_lysosome_morphology | 1.63012151 |
| 25 | MP0001915_intracranial_hemorrhage | 1.58495936 |
| 26 | MP0002132_abnormal_respiratory_system | 1.56696294 |
| 27 | MP0003123_paternal_imprinting | 1.54261092 |
| 28 | MP0001661_extended_life_span | 1.38329389 |
| 29 | MP0005670_abnormal_white_adipose | 1.20562552 |
| 30 | MP0004019_abnormal_vitamin_homeostasis | 1.18914987 |
| 31 | MP0000598_abnormal_liver_morphology | 1.18420163 |
| 32 | MP0002876_abnormal_thyroid_physiology | 1.14549362 |
| 33 | MP0001764_abnormal_homeostasis | 1.14260870 |
| 34 | MP0005409_darkened_coat_color | 1.12841841 |
| 35 | MP0003656_abnormal_erythrocyte_physiolo | 1.06865388 |
| 36 | MP0005319_abnormal_enzyme/_coenzyme | 1.01720853 |
| 37 | MP0009780_abnormal_chondrocyte_physiolo | 1.01493244 |
| 38 | MP0000604_amyloidosis | 0.97561058 |
| 39 | MP0009697_abnormal_copulation | 0.97550378 |
| 40 | MP0000639_abnormal_adrenal_gland | 0.94976799 |
| 41 | MP0009642_abnormal_blood_homeostasis | 0.92845963 |
| 42 | MP0005636_abnormal_mineral_homeostasis | 0.91827035 |
| 43 | MP0009643_abnormal_urine_homeostasis | 0.88920407 |
| 44 | MP0005464_abnormal_platelet_physiology | 0.88416875 |
| 45 | MP0002971_abnormal_brown_adipose | 0.83663276 |
| 46 | MP0003879_abnormal_hair_cell | 0.82006524 |
| 47 | MP0005257_abnormal_intraocular_pressure | 0.80317445 |
| 48 | MP0009384_cardiac_valve_regurgitation | 0.79693387 |
| 49 | MP0005167_abnormal_blood-brain_barrier | 0.78016472 |
| 50 | MP0004272_abnormal_basement_membrane | 0.76940355 |
| 51 | MP0006054_spinal_hemorrhage | 0.76781509 |
| 52 | MP0005084_abnormal_gallbladder_morpholo | 0.75936898 |
| 53 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.74181428 |
| 54 | MP0002249_abnormal_larynx_morphology | 0.70783213 |
| 55 | MP0000678_abnormal_parathyroid_gland | 0.70498147 |
| 56 | MP0003878_abnormal_ear_physiology | 0.70216795 |
| 57 | MP0005377_hearing/vestibular/ear_phenot | 0.70216795 |
| 58 | MP0002078_abnormal_glucose_homeostasis | 0.68890530 |
| 59 | MP0008260_abnormal_autophagy | 0.68226007 |
| 60 | MP0002282_abnormal_trachea_morphology | 0.66734045 |
| 61 | MP0003121_genomic_imprinting | 0.64713134 |
| 62 | MP0003115_abnormal_respiratory_system | 0.64466685 |
| 63 | MP0004264_abnormal_extraembryonic_tissu | 0.61758321 |
| 64 | MP0008469_abnormal_protein_level | 0.60730848 |
| 65 | MP0009115_abnormal_fat_cell | 0.59959655 |
| 66 | MP0005220_abnormal_exocrine_pancreas | 0.59900683 |
| 67 | MP0006292_abnormal_olfactory_placode | 0.59556668 |
| 68 | MP0005448_abnormal_energy_balance | 0.58873760 |
| 69 | MP0005076_abnormal_cell_differentiation | 0.57339720 |
| 70 | MP0000003_abnormal_adipose_tissue | 0.56705266 |
| 71 | MP0003806_abnormal_nucleotide_metabolis | 0.56542097 |
| 72 | MP0003567_abnormal_fetal_cardiomyocyte | 0.56444790 |
| 73 | MP0003329_amyloid_beta_deposits | 0.56318568 |
| 74 | MP0003183_abnormal_peptide_metabolism | 0.55707714 |
| 75 | MP0002933_joint_inflammation | 0.55212986 |
| 76 | MP0002092_abnormal_eye_morphology | 0.54483773 |
| 77 | MP0003011_delayed_dark_adaptation | 0.51552345 |
| 78 | MP0005395_other_phenotype | 0.51077566 |
| 79 | MP0003953_abnormal_hormone_level | 0.50807561 |
| 80 | MP0003315_abnormal_perineum_morphology | 0.50453170 |
| 81 | MP0001270_distended_abdomen | 0.49868587 |
| 82 | MP0009763_increased_sensitivity_to | 0.49522145 |
| 83 | MP0002909_abnormal_adrenal_gland | 0.47202486 |
| 84 | MP0005376_homeostasis/metabolism_phenot | 0.47157624 |
| 85 | MP0001756_abnormal_urination | 0.45827730 |
| 86 | MP0000858_altered_metastatic_potential | 0.45756026 |
| 87 | MP0002168_other_aberrant_phenotype | 0.45124623 |
| 88 | MP0003950_abnormal_plasma_membrane | 0.43890171 |
| 89 | MP0003566_abnormal_cell_adhesion | 0.43243538 |
| 90 | MP0005083_abnormal_biliary_tract | 0.43023276 |
| 91 | MP0005164_abnormal_response_to | 0.42872570 |
| 92 | MP0005334_abnormal_fat_pad | 0.42323230 |
| 93 | MP0002970_abnormal_white_adipose | 0.41658359 |
| 94 | MP0005023_abnormal_wound_healing | 0.41355838 |
| 95 | MP0004883_abnormal_blood_vessel | 0.41114852 |
| 96 | MP0003942_abnormal_urinary_system | 0.39280962 |
| 97 | MP0003690_abnormal_glial_cell | 0.38167200 |
| 98 | MP0000249_abnormal_blood_vessel | 0.37993175 |
| 99 | MP0003943_abnormal_hepatobiliary_system | 0.36874110 |
| 100 | MP0003632_abnormal_nervous_system | 0.35668675 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged partial thromboplastin time (HP:0003645) | 8.54070958 |
| 2 | Complement deficiency (HP:0004431) | 7.72143107 |
| 3 | Joint hemorrhage (HP:0005261) | 7.56257001 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 6.88371079 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.47093835 |
| 6 | Abnormality of complement system (HP:0005339) | 6.03546682 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.85892446 |
| 8 | Xanthomatosis (HP:0000991) | 5.47316531 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 5.31366426 |
| 10 | Abnormality of the common coagulation pathway (HP:0010990) | 5.03447110 |
| 11 | Glomerulonephritis (HP:0000099) | 4.98107618 |
| 12 | Hemorrhage of the eye (HP:0011885) | 4.47738013 |
| 13 | Hypercholesterolemia (HP:0003124) | 4.47677854 |
| 14 | Spontaneous abortion (HP:0005268) | 4.41811132 |
| 15 | Hypolipoproteinemia (HP:0010981) | 4.39843320 |
| 16 | Conjugated hyperbilirubinemia (HP:0002908) | 4.19777978 |
| 17 | Hyperlipoproteinemia (HP:0010980) | 4.12350607 |
| 18 | Menorrhagia (HP:0000132) | 3.72949052 |
| 19 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.47960531 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 3.37452680 |
| 21 | Intrahepatic cholestasis (HP:0001406) | 3.28757253 |
| 22 | Purpura (HP:0000979) | 3.19833394 |
| 23 | Vascular calcification (HP:0004934) | 3.15753519 |
| 24 | Epidermoid cyst (HP:0200040) | 3.14836332 |
| 25 | Gingival bleeding (HP:0000225) | 3.13246287 |
| 26 | Abnormality of the intrinsic pathway (HP:0010989) | 3.07002669 |
| 27 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.97655986 |
| 28 | Mitral stenosis (HP:0001718) | 2.94273897 |
| 29 | Nephritis (HP:0000123) | 2.92570669 |
| 30 | Abnormality of carpal bone ossification (HP:0006257) | 2.87737273 |
| 31 | Cardiovascular calcification (HP:0011915) | 2.75318439 |
| 32 | Hypophosphatemic rickets (HP:0004912) | 2.69546535 |
| 33 | Thrombophlebitis (HP:0004418) | 2.68356322 |
| 34 | Acanthocytosis (HP:0001927) | 2.57480337 |
| 35 | Myocardial infarction (HP:0001658) | 2.55148065 |
| 36 | Fat malabsorption (HP:0002630) | 2.51151995 |
| 37 | Hepatocellular carcinoma (HP:0001402) | 2.50607810 |
| 38 | Broad alveolar ridges (HP:0000187) | 2.44349604 |
| 39 | Abnormal tarsal ossification (HP:0008369) | 2.40578557 |
| 40 | Hyperglycinemia (HP:0002154) | 2.39790216 |
| 41 | Small epiphyses (HP:0010585) | 2.36513109 |
| 42 | Rickets (HP:0002748) | 2.33739340 |
| 43 | Osteomalacia (HP:0002749) | 2.29585295 |
| 44 | Vaginal fistula (HP:0004320) | 2.28420680 |
| 45 | Enlarged kidneys (HP:0000105) | 2.28329621 |
| 46 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.21591045 |
| 47 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.19041496 |
| 48 | Skin nodule (HP:0200036) | 2.16368447 |
| 49 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.14209138 |
| 50 | Abnormality of glycine metabolism (HP:0010895) | 2.14209138 |
| 51 | Abnormal ossification of hand bones (HP:0005921) | 2.10756996 |
| 52 | Flat acetabular roof (HP:0003180) | 2.09973821 |
| 53 | Asymmetry of the thorax (HP:0001555) | 2.08737120 |
| 54 | Abnormal hand bone ossification (HP:0010660) | 2.07812597 |
| 55 | Facial shape deformation (HP:0011334) | 2.05610898 |
| 56 | Potter facies (HP:0002009) | 2.05610898 |
| 57 | Pulmonary embolism (HP:0002204) | 2.00555757 |
| 58 | Arthropathy (HP:0003040) | 2.00248185 |
| 59 | Gout (HP:0001997) | 2.00182594 |
| 60 | Deep venous thrombosis (HP:0002625) | 11.3485709 |
| 61 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.99963096 |
| 62 | Bifid scrotum (HP:0000048) | 1.97974764 |
| 63 | Broad palm (HP:0001169) | 1.97028827 |
| 64 | Poikilocytosis (HP:0004447) | 1.96378950 |
| 65 | Abnormality of methionine metabolism (HP:0010901) | 1.95873813 |
| 66 | Abnormality of the lumbar spine (HP:0100712) | 1.95317803 |
| 67 | Delayed CNS myelination (HP:0002188) | 1.94640116 |
| 68 | Hyperglycinuria (HP:0003108) | 1.88646726 |
| 69 | Increased serum pyruvate (HP:0003542) | 1.86542163 |
| 70 | Generalized aminoaciduria (HP:0002909) | 1.83699179 |
| 71 | Flared iliac wings (HP:0002869) | 1.82181042 |
| 72 | Widely patent fontanelles and sutures (HP:0004492) | 1.80678908 |
| 73 | Protrusio acetabuli (HP:0003179) | 1.80290981 |
| 74 | Epiphyseal dysplasia (HP:0002656) | 1.78806545 |
| 75 | Abnormality of the Achilles tendon (HP:0005109) | 1.78519618 |
| 76 | Hepatoblastoma (HP:0002884) | 1.78312147 |
| 77 | Hyperammonemia (HP:0001987) | 1.78256914 |
| 78 | Abnormality of proline metabolism (HP:0010907) | 1.77031303 |
| 79 | Hydroxyprolinuria (HP:0003080) | 1.77031303 |
| 80 | Alacrima (HP:0000522) | 1.73756628 |
| 81 | Amyloidosis (HP:0011034) | 1.72900371 |
| 82 | Abnormal delivery (HP:0001787) | 1.72887407 |
| 83 | Hypoglycemic coma (HP:0001325) | 1.71837919 |
| 84 | Abnormality of glycolysis (HP:0004366) | 1.69717259 |
| 85 | Epistaxis (HP:0000421) | 1.68708861 |
| 86 | Pigmentary retinal degeneration (HP:0001146) | 1.68270267 |
| 87 | Gonadal dysgenesis (HP:0000133) | 1.63581270 |
| 88 | Neonatal death (HP:0003811) | 1.63038893 |
| 89 | Abnormal gallbladder physiology (HP:0012438) | 1.63016059 |
| 90 | Cholecystitis (HP:0001082) | 1.63016059 |
| 91 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.61156897 |
| 92 | Abnormality of the nasal septum (HP:0000419) | 1.60330536 |
| 93 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.58692124 |
| 94 | Mucopolysacchariduria (HP:0008155) | 1.58692124 |
| 95 | Abnormality of pain sensation (HP:0010832) | 1.56977375 |
| 96 | Impaired pain sensation (HP:0007328) | 1.56977375 |
| 97 | Reticulocytosis (HP:0001923) | 1.56886001 |
| 98 | Abnormality of the vitreous humor (HP:0004327) | 1.53206756 |
| 99 | Bronchomalacia (HP:0002780) | 1.51810896 |
| 100 | Abnormality of nucleobase metabolism (HP:0010932) | 1.51068300 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FGFR4 | 7.86338532 |
| 2 | FGFR3 | 4.61705509 |
| 3 | ICK | 3.82327887 |
| 4 | WNK4 | 3.71457781 |
| 5 | ERN1 | 3.57944386 |
| 6 | TRIB3 | 3.07752851 |
| 7 | RIPK1 | 2.65731287 |
| 8 | CDK12 | 2.55837557 |
| 9 | TYRO3 | 2.52749236 |
| 10 | SIK1 | 2.33597418 |
| 11 | FGFR2 | 2.18920558 |
| 12 | PDGFRA | 2.16676904 |
| 13 | FGFR1 | 1.93139151 |
| 14 | DYRK1B | 1.86334626 |
| 15 | PKN2 | 1.80135141 |
| 16 | PIK3CA | 1.71139015 |
| 17 | SIK2 | 1.64843966 |
| 18 | DDR2 | 1.56926568 |
| 19 | WNK1 | 1.56724038 |
| 20 | EEF2K | 1.53898777 |
| 21 | PRKAA2 | 1.43080660 |
| 22 | MAPK11 | 1.41165807 |
| 23 | RET | 1.33359315 |
| 24 | EPHA2 | 1.26777982 |
| 25 | PDPK1 | 1.26234159 |
| 26 | AKT3 | 1.25908083 |
| 27 | SMG1 | 1.17957846 |
| 28 | FGR | 1.06013967 |
| 29 | IRAK3 | 1.04693869 |
| 30 | ERBB2 | 1.03108547 |
| 31 | MAP3K7 | 0.98159688 |
| 32 | LATS1 | 0.97950413 |
| 33 | NTRK3 | 0.94495702 |
| 34 | CDK7 | 0.94195176 |
| 35 | PDK1 | 0.91353270 |
| 36 | MAP3K2 | 0.87116353 |
| 37 | CSF1R | 0.83035852 |
| 38 | TYK2 | 0.82941564 |
| 39 | CDC42BPA | 0.80381360 |
| 40 | MAP2K3 | 0.79373356 |
| 41 | PRKAA1 | 0.76665910 |
| 42 | TGFBR2 | 0.72958011 |
| 43 | SGK223 | 0.72133825 |
| 44 | SGK494 | 0.72133825 |
| 45 | MAP2K6 | 0.71480636 |
| 46 | NEK9 | 0.69913382 |
| 47 | MATK | 0.68106303 |
| 48 | NEK2 | 0.66934112 |
| 49 | MAP3K3 | 0.65391331 |
| 50 | MTOR | 0.65182701 |
| 51 | PTK6 | 0.63819771 |
| 52 | RPS6KB1 | 0.62713246 |
| 53 | MAP3K11 | 0.61742906 |
| 54 | EIF2AK1 | 0.60747056 |
| 55 | MST1R | 0.60371893 |
| 56 | EPHA4 | 0.60343335 |
| 57 | SGK3 | 0.60281634 |
| 58 | PRKACG | 0.59499308 |
| 59 | MARK2 | 0.58260208 |
| 60 | MAP3K1 | 0.58002935 |
| 61 | MET | 0.57887665 |
| 62 | SGK1 | 0.56226039 |
| 63 | CDK4 | 0.55549186 |
| 64 | CAMK1D | 0.53696968 |
| 65 | MAPKAPK3 | 0.53165481 |
| 66 | PTK2 | 0.51850612 |
| 67 | CSNK1E | 0.51116671 |
| 68 | KSR2 | 0.49905078 |
| 69 | MAP2K4 | 0.44533933 |
| 70 | PDGFRB | 0.44386328 |
| 71 | GRK6 | 0.43458872 |
| 72 | PRKCZ | 0.39420822 |
| 73 | BRSK1 | 0.38278524 |
| 74 | IGF1R | 0.37475774 |
| 75 | SRC | 0.36978341 |
| 76 | BRD4 | 0.36873827 |
| 77 | SGK2 | 0.36641083 |
| 78 | FLT3 | 0.31974424 |
| 79 | NTRK2 | 0.30377387 |
| 80 | CDK8 | 0.30225435 |
| 81 | MAP3K5 | 0.30062726 |
| 82 | MAPK3 | 0.29954081 |
| 83 | CSNK1D | 0.28360780 |
| 84 | CAMK1G | 0.27272080 |
| 85 | LATS2 | 0.26764409 |
| 86 | CDK6 | 0.26409008 |
| 87 | CDK9 | 0.25898745 |
| 88 | PRPF4B | 0.25679508 |
| 89 | MELK | 0.24796485 |
| 90 | RPS6KA3 | 0.23914529 |
| 91 | MAP3K6 | 0.23430069 |
| 92 | CAMK4 | 0.22687690 |
| 93 | ITK | 0.20815088 |
| 94 | ZAP70 | 0.20276145 |
| 95 | EPHB1 | 0.20079380 |
| 96 | MAPK1 | 0.19999623 |
| 97 | TAOK2 | 0.19995978 |
| 98 | CSNK2A2 | 0.19442675 |
| 99 | MAP3K13 | 0.19083505 |
| 100 | PRKG1 | 0.18723763 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 5.29735156 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.55748286 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.84302835 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.75557833 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.71187336 |
| 6 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.58229863 |
| 7 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.47384729 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.43695664 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.43384037 |
| 10 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.34233981 |
| 11 | Retinol metabolism_Homo sapiens_hsa00830 | 2.31852384 |
| 12 | Histidine metabolism_Homo sapiens_hsa00340 | 2.14965612 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.13223905 |
| 14 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.10430475 |
| 15 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.03343430 |
| 16 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.00153859 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.95814067 |
| 18 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.95435048 |
| 19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.93099596 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.92000556 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.80995685 |
| 22 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.74147625 |
| 23 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.72337876 |
| 24 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.70515350 |
| 25 | Bile secretion_Homo sapiens_hsa04976 | 1.69580981 |
| 26 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.63499067 |
| 27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.59395276 |
| 28 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.58389901 |
| 29 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.54661687 |
| 30 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.53983465 |
| 31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.53103661 |
| 32 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.48152984 |
| 33 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.39586528 |
| 34 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.38681519 |
| 35 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.38549091 |
| 36 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.34796777 |
| 37 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.34548565 |
| 38 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.32134025 |
| 39 | ABC transporters_Homo sapiens_hsa02010 | 1.29258604 |
| 40 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.28308803 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.22754974 |
| 42 | Prion diseases_Homo sapiens_hsa05020 | 1.22540653 |
| 43 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.22204565 |
| 44 | Peroxisome_Homo sapiens_hsa04146 | 1.11719683 |
| 45 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.09151794 |
| 46 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.09033470 |
| 47 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.07404290 |
| 48 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.06919091 |
| 49 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.02982580 |
| 50 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.02427758 |
| 51 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.92139410 |
| 52 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.90028627 |
| 53 | Carbon metabolism_Homo sapiens_hsa01200 | 0.87617951 |
| 54 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.83777034 |
| 55 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.83732570 |
| 56 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.81545816 |
| 57 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.79623522 |
| 58 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.72966406 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.71309945 |
| 60 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.70089406 |
| 61 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.65600093 |
| 62 | Galactose metabolism_Homo sapiens_hsa00052 | 0.63453293 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.62755902 |
| 64 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.60530872 |
| 65 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.59075313 |
| 66 | Insulin resistance_Homo sapiens_hsa04931 | 0.57744063 |
| 67 | Sulfur relay system_Homo sapiens_hsa04122 | 0.54890601 |
| 68 | Pertussis_Homo sapiens_hsa05133 | 0.51608243 |
| 69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50881397 |
| 70 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.48856065 |
| 71 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.45689063 |
| 72 | Mineral absorption_Homo sapiens_hsa04978 | 0.41342267 |
| 73 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39947357 |
| 74 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.34104345 |
| 75 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.33806939 |
| 76 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.29528417 |
| 77 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.28574777 |
| 78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.28511656 |
| 79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.24600117 |
| 80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23670096 |
| 81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.22104128 |
| 82 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.21737182 |
| 83 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.19857845 |
| 84 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.18198523 |
| 85 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.17977829 |
| 86 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.16103612 |
| 87 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.15249870 |
| 88 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.10018691 |
| 89 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.09742289 |
| 90 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.09713609 |
| 91 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.08876880 |
| 92 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.07597933 |
| 93 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.05678164 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.03364671 |
| 95 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0817504 |
| 96 | Non-small cell lung cancer_Homo sapiens_hsa05223 | -0.0730204 |
| 97 | Amoebiasis_Homo sapiens_hsa05146 | -0.0380180 |
| 98 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0286666 |
| 99 | Selenocompound metabolism_Homo sapiens_hsa00450 | -0.0126562 |
| 100 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.0059779 |

